Condition: Haemorrhagic Hereditary Telangiectasia · Sponsor: Hospital Italiano de Buenos Aires
The purpose of this study is to create an institutional and population-based registry of Haemorrhagic Hereditary Telangiectasia with a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival. This study will also describe the occurrence of Haemorrhagic Hereditary Telangiectasia in the population of HIBA in the Central Hospital, as well as the characteristics of clinical presentation and evolution.
This description comes directly from the study's public registry record.
Marcelo M Serra, MD · +541149590200 · marcelo.serra@hospitalitaliano.org.ar
Diego H Giunta, MD · +541149590200 · diego.giunta@hospitalitaliano.org.ar
Always discuss trial participation with your own doctor first.
| Hospital Italiano de Buenos Aires | Buenos Aires, Buenos Aires, Argentina | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01761981